{"id":3470,"date":"2022-10-19T19:55:48","date_gmt":"2022-10-19T19:55:48","guid":{"rendered":"https:\/\/clinicaltrials.allmedia.rs\/?page_id=3470"},"modified":"2023-06-25T15:04:51","modified_gmt":"2023-06-25T15:04:51","slug":"about-us","status":"publish","type":"page","link":"https:\/\/clinicaltrials.rs\/sr\/about-us\/","title":{"rendered":"O klini\u010dkim ispitivanjima"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"3470\" class=\"elementor elementor-3470\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-65c81e5b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"65c81e5b\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-197f861a\" data-id=\"197f861a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-33308788 elementor-widget elementor-widget-laborex_future_member_content1\" data-id=\"33308788\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"laborex_future_member_content1.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t \r\n\t\t<div class=\"content-one\">\r\n\t\t\t<div class=\"text\">\r\n\t\t\t\t<h3>O klini\u010dkim ispitivanjima<\/h3>\r\n\t\t\t\t<p><em>Svaki lek koji je danas dostupan nastao je zahvaljuju\u0107i klini\u010dkim ispitivanjima i pacijentima koji su bili voljni da\nu\u010destvuju u studijama.<\/em><\/p>\t\t\t<\/div>\r\n\t\t\t<figure class=\"image\">\r\n\t\t\t\t<div class=\"shape rotate-me\" style=\"background-image: url();\"><\/div>\r\n\t\t\t\t\t\t\t<\/figure>\r\n\t\t<\/div> \r\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7aa7732 elementor-widget elementor-widget-laborex_future_member_content1\" data-id=\"7aa7732\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"laborex_future_member_content1.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t \r\n\t\t<div class=\"content-one\">\r\n\t\t\t<div class=\"text\">\r\n\t\t\t\t<h3>\u0160ta su klini\u010dke studije?<\/h3>\r\n\t\t\t\t<p>Klini\u010dke studije podrazumevaju ispitivanja koja se sprovode na ljudskoj populaciji da bi se ispitala ili potvrdila\nbezbednost i efikasnost ispitivanog medicinskog sredstva ili leka. Da bi novi, bezbedniji i efikasniji lekovi bili dostupni\npacijentima, potrebno je da pro\u0111u kroz kompleksan, vi\u0161egodi\u0161nji istra\u017eiva\u010dki proces.<\/p><p>\u010citav proces po\u010dinje u laboratoriji, tkz. In-vitro ispitivanjima supstance koja je kandidat za novi lek. Ukoliko su rezultati\nobe\u0107avaju\u0107i, slede kompleksna ispitivanja na eksperimentalnim \u017eivotinjama, kako bi se prou\u010dili efekti leka u \u017eivom\norganizmu. Nakon ekstenzivnog prikupljanja i analize podataka iz ove faze, ukoliko su ispunjeni svi uslovi za dobijanje\nodobrenja od regulatornih tela, slede klini\u010dka ispitivanja, gde se lek testira u humanoj populaciji. To omogu\u0107ava\nprocenu bezbednosti i efikasnosti novog leka, a tako\u0111e omogu\u0107ava lekaru da pacijentu pru\u017ei novu opciju le\u010denja\nodre\u0111enog oboljenja.<\/p><p><em>Samo 1 od 10 ispitivanih lekova uspe\u0161no prolazi klini\u010dka ispitivanja i dobija odobrenje da se mo\u017ee pojaviti na tr\u017ei\u0161tu\nkao lek koji se koristi u klini\u010dkoj praksi.<\/em><\/p>\t\t\t<\/div>\r\n\t\t\t<figure class=\"image\">\r\n\t\t\t\t<div class=\"shape rotate-me\" style=\"background-image: url(https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2021\/05\/shape-58.png);\"><\/div>\r\n\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"2560\" height=\"1009\" src=\"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials1-scaled.jpg\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials1-scaled.jpg 2560w, https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials1-300x118.jpg 300w, https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials1-1024x404.jpg 1024w, https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials1-768x303.jpg 768w, https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials1-1536x605.jpg 1536w, https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials1-2048x807.jpg 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" \/>\t\t\t<\/figure>\r\n\t\t<\/div> \r\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-76f427d elementor-widget elementor-widget-laborex_future_member_content1\" data-id=\"76f427d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"laborex_future_member_content1.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t \r\n\t\t<div class=\"content-one\">\r\n\t\t\t<div class=\"text\">\r\n\t\t\t\t<h3>Kako zapravo izgleda jedna klini\u010dka studija?<\/h3>\r\n\t\t\t\t<p>Bitno je naglasiti da je u\u010de\u0161\u0107e pacijenta u klini\u010dkoj studiji u potpunosti na dobrovoljnoj bazi, i svaki u\u010desnik potpisuje\ninformisani pristanak pre uklju\u010divanja u studiju. Pacijent ima pravo da se, u bilo kom trenutku i iz bilo kojeg razloga,\npovu\u010de iz klini\u010dke studije, bez ikakvih pravnih ili drugih posledica.<\/p><p class=\"translation-block\">U najve\u0107em broju slu\u010dajeva, dizajn studije je takav da su pacijenti podeljeni u dve grupe. Pacijenti u jednoj grupi\nprimaju ispitivani lek, dok pacijenti druge grupe (kontrolna grupa) primaju placebo. Placebo je farmakolo\u0161ki neaktivni\npreparat (nema nikakav efekat), koji je dizajniran da izgleda isto kao ispitivani lek i slu\u017ei da se u odnosu na njega\nproveri efikasnost leka. Tako\u0111e, studija mo\u017ee da bude dizajnirana i bez placeba, gde kontrolna grupa umesto placeba\nprima drugi lek koji je ve\u0107 na tr\u017ei\u0161tu.<\/p><p>Pojedine studije su dizajnirane tako da pacijenti i istra\u017eiva\u010di ne znaju koji pacijent prima lek, a koji placebo. To\nomogu\u0107ava lekaru da objektivno analizira sve efekte novog leka i izvede pravilne zaklju\u010dke. Bez obzira na to da li prima\nispitivani lek ili placebo, svaki pacijent je tretiran podjednako, dobija istu negu, prolazi ista ispitivanja i njegova\nbezbednost je na prvom mestu.<\/p>\t\t\t<\/div>\r\n\t\t\t<figure class=\"image\">\r\n\t\t\t\t<div class=\"shape rotate-me\" style=\"background-image: url(https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2021\/05\/shape-58.png);\"><\/div>\r\n\t\t\t\t<img decoding=\"async\" width=\"770\" height=\"248\" src=\"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials2.jpg\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials2.jpg 770w, https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials2-300x97.jpg 300w, https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/11\/Abouttrials2-768x247.jpg 768w\" sizes=\"(max-width: 770px) 100vw, 770px\" \/>\t\t\t<\/figure>\r\n\t\t<\/div> \r\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4c1b0005 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4c1b0005\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3a1dadb\" data-id=\"3a1dadb\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bfb4894 elementor-widget elementor-widget-laborex_future_member_content3\" data-id=\"bfb4894\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"laborex_future_member_content3.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t \r\n\t\t<div class=\"content-three\">\r\n\t\t\t<div class=\"text\">\r\n\t\t\t\t<h3>Ko mo\u017ee da u\u010destvuje u klini\u010dkim ispitivanjima?<\/h3>\r\n\t\t\t\t<p>Za svaku studiju postoje detaljne smernice koje govore koji pacijenti mogu da se uklju\u010de u tu studiju i potencijalni\nu\u010desnici moraju da ih ispune da bi bili uvr\u0161teni.<\/p><p>Uslovi koji moraju biti ispunjeni da bi pacijent bio uvr\u0161ten u studiju se zovu kriterijumi za uklju\u010divanje. Nasuprot tome,\nsvi faktori koji mogu da spre\u010de pacijenta da bude uklju\u010den se nazivaju kriterijumi za isklju\u010denje, i dovoljno je da je\nprisutan samo jedan od njih da pacijent ne bi bio uklju\u010den.<\/p><p>Primer ovih kriterijuma su godine starosti, pol, vrsta i stepen\noboljenja, podaci iz medicinske istorije pacijenta, dodatna terapija koju pacijent koristi. Svaka studija ima svoj set\nkriterijuma i svaka se sprovodi za odre\u0111eno stanje ili oboljenje. <\/p>\t\t\t<\/div>\r\n\t\t\t<div class=\"form-inner\">\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div> \r\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-09120fc elementor-widget elementor-widget-laborex_future_member_content3\" data-id=\"09120fc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"laborex_future_member_content3.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t \r\n\t\t<div class=\"content-three\">\r\n\t\t\t<div class=\"text\">\r\n\t\t\t\t<h3>\u0160ta je informisani pristanak?<\/h3>\r\n\t\t\t\t<p>Pre nego \u0161to se uklju\u010di u studiju, svaki pacijent ima pravo da zna i da razume \u0161ta podrazumeva u\u010de\u0161\u0107e u studiji. Taj\nproces se naziva informisani pristanak.<\/p><p><br \/>Informisani pristanak podrazumeva interaktivnu komunikaciju izme\u0111u pacijent i lekara, sa ciljem da pacijentu u\npotpunosti, na njemu razumljiv na\u010din, bude razja\u0161njeno \u0161ta sve nosi u\u010de\u0161\u0107e u studiji. To uklju\u010duje i\ninformacije o tome da li se u studiji koristi placebo i koja je verovatno\u0107a da pacijent bude u grupi koja prima placebo,\nzatim da li postoje ve\u0107 dostupni lekovi ili tretmani na tr\u017ei\u0161tu za ispitivano oboljenje, o svim potencijalnim rizicima ili\nbenefitima uklju\u010divanja u studiju. Dakle, informisani pristanak je daleko vi\u0161e od samog potpisivanja formulara.<\/p><p>Potpisivanjem informisanog pristanka, pacijent potvr\u0111uje da svojom slobodnom voljom pristupa klini\u010dkoj studiji, kao i\nda je upoznat sa svim potencijalnim posledicama i benefitima koje to u\u010de\u0161\u0107e nosi. Uprkos tome, pacijent svakako ima\npravo da, u bilo kom trenutku i iz bilo kog razloga, povu\u010de svoj pristanak i napusti studiju. <\/p>\t\t\t<\/div>\r\n\t\t\t<div class=\"form-inner\">\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div> \r\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6d9ef7d elementor-widget elementor-widget-laborex_future_member_content3\" data-id=\"6d9ef7d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"laborex_future_member_content3.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t \r\n\t\t<div class=\"content-three\">\r\n\t\t\t<div class=\"text\">\r\n\t\t\t\t<h3>Zbog \u010dega se pacijenti uklju\u010duju u klini\u010dka ispitivanja?<\/h3>\r\n\t\t\t\t<p>Svaki pacijent ima sopstveni razlog za priklju\u010divanje studiji.\nZa neke, razlog mogu da budu razli\u010dite medicinske usluge koje su deo protokola studije, a za druge to mo\u017ee da bude\n\u0161ansa da dobiju novi lek koji bi mogao da im pomogne.<\/p><p>Jo\u0161 jednom, bitno je naglasiti da je u\u010de\u0161\u0107e u studiji apsolutno na dobrovoljnoj fazi i da svaki pacijent treba da\nprodiskutuje detaljno sa svojim lekarom o svim mogu\u0107im prednostima ili posledicama uklju\u010divanja u studiju.\nMi, u MSB Centru za klini\u010dka ispitivanja, se staramo o tome da pacijent dobije sve potrebne informacije da bi doneo\ninformisanu odluku o pristupu studiji. <\/p>\t\t\t<\/div>\r\n\t\t\t<div class=\"form-inner\">\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div> \r\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-78674f8 elementor-widget elementor-widget-laborex_future_member_content3\" data-id=\"78674f8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"laborex_future_member_content3.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t \r\n\t\t<div class=\"content-three\">\r\n\t\t\t<div class=\"text\">\r\n\t\t\t\t<h3>Za vi\u0161e informacija posetite<\/h3>\r\n\t\t\t\t<p><a href=\"https:\/\/www.alims.gov.rs\/humani-lekovi\/informacije-o-lekovima-i-klinickim-ispitivanjima\/\">ALIMS \u2013 Agencija za lekove i medicinska sredstva<\/a> <br \/><a href=\"https:\/\/www.alims.gov.rs\/wp-content\/uploads\/2022\/01\/KI-Brosura.pdf\">Brochure for participants and potential participants in clinical trials, by ALIMS<\/a><br \/><a href=\"https:\/\/www.eos.gov.rs\/lekovi\/\">EOS \u2013 Ethic committee of Serbia<\/a>\u00a0<\/p>\t\t\t<\/div>\r\n\t\t\t<div class=\"form-inner\">\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div> \r\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>About clinical trials All the treatments and medications used regularly today were made possible by past clinical trials and the patients who participated in them. What is clinical research? A [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4067,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3470","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medical System Belgrade | Serbia Clinical Research | MSB CRC<\/title>\n<meta name=\"description\" content=\"Medical System Belgrade, specialized clinical research center in Serbia. New drugs and medication research. Phase 1-4 studies. IATA certified\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clinicaltrials.rs\/sr\/about-us\/\" \/>\n<meta property=\"og:locale\" content=\"sr_RS\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medical System Belgrade | Serbia Clinical Research | MSB CRC\" \/>\n<meta property=\"og:description\" content=\"Medical System Belgrade, specialized clinical research center in Serbia. New drugs and medication research. Phase 1-4 studies. IATA certified\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clinicaltrials.rs\/sr\/about-us\/\" \/>\n<meta property=\"og:site_name\" content=\"MSB Clinical Research Center\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-25T15:04:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/12\/page-title.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u041f\u0440\u043e\u0446\u0435\u045a\u0435\u043d\u043e \u0432\u0440\u0435\u043c\u0435 \u0447\u0438\u0442\u0430\u045a\u0430\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 \u043c\u0438\u043d\u0443\u0442\u0430\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/sr\\\/about-us\\\/\",\"url\":\"https:\\\/\\\/clinicaltrials.rs\\\/sr\\\/about-us\\\/\",\"name\":\"Medical System Belgrade | Serbia Clinical Research | MSB CRC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/sr\\\/about-us\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/sr\\\/about-us\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/clinicaltrials.rs\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/page-title.jpg\",\"datePublished\":\"2022-10-19T19:55:48+00:00\",\"dateModified\":\"2023-06-25T15:04:51+00:00\",\"description\":\"Medical System Belgrade, specialized clinical research center in Serbia. New drugs and medication research. Phase 1-4 studies. IATA certified\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/sr\\\/about-us\\\/#breadcrumb\"},\"inLanguage\":\"sr-RS\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/clinicaltrials.rs\\\/sr\\\/about-us\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sr-RS\",\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/sr\\\/about-us\\\/#primaryimage\",\"url\":\"https:\\\/\\\/clinicaltrials.rs\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/page-title.jpg\",\"contentUrl\":\"https:\\\/\\\/clinicaltrials.rs\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/page-title.jpg\",\"width\":1920,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/sr\\\/about-us\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/clinicaltrials.rs\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"About clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/#website\",\"url\":\"https:\\\/\\\/clinicaltrials.rs\\\/\",\"name\":\"MSB Clinical Research Center\",\"description\":\"Clinical Research Done Right\",\"publisher\":{\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/#organization\"},\"alternateName\":\"Centar za klini\u010dka ispitivanja\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/clinicaltrials.rs\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sr-RS\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/#organization\",\"name\":\"MSB Clinical Research Center\",\"alternateName\":\"Clinical Research Center\",\"url\":\"https:\\\/\\\/clinicaltrials.rs\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sr-RS\",\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/clinicaltrials.rs\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Web_Logo.png\",\"contentUrl\":\"https:\\\/\\\/clinicaltrials.rs\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Web_Logo.png\",\"width\":400,\"height\":114,\"caption\":\"MSB Clinical Research Center\"},\"image\":{\"@id\":\"https:\\\/\\\/clinicaltrials.rs\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medical System Belgrade | Serbia Clinical Research | MSB CRC","description":"Medical System Belgrade, specialized clinical research center in Serbia. New drugs and medication research. Phase 1-4 studies. IATA certified","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clinicaltrials.rs\/sr\/about-us\/","og_locale":"sr_RS","og_type":"article","og_title":"Medical System Belgrade | Serbia Clinical Research | MSB CRC","og_description":"Medical System Belgrade, specialized clinical research center in Serbia. New drugs and medication research. Phase 1-4 studies. IATA certified","og_url":"https:\/\/clinicaltrials.rs\/sr\/about-us\/","og_site_name":"MSB Clinical Research Center","article_modified_time":"2023-06-25T15:04:51+00:00","og_image":[{"width":1920,"height":338,"url":"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/12\/page-title.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"\u041f\u0440\u043e\u0446\u0435\u045a\u0435\u043d\u043e \u0432\u0440\u0435\u043c\u0435 \u0447\u0438\u0442\u0430\u045a\u0430":"4 \u043c\u0438\u043d\u0443\u0442\u0430"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/clinicaltrials.rs\/sr\/about-us\/","url":"https:\/\/clinicaltrials.rs\/sr\/about-us\/","name":"Medical System Belgrade | Serbia Clinical Research | MSB CRC","isPartOf":{"@id":"https:\/\/clinicaltrials.rs\/#website"},"primaryImageOfPage":{"@id":"https:\/\/clinicaltrials.rs\/sr\/about-us\/#primaryimage"},"image":{"@id":"https:\/\/clinicaltrials.rs\/sr\/about-us\/#primaryimage"},"thumbnailUrl":"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/12\/page-title.jpg","datePublished":"2022-10-19T19:55:48+00:00","dateModified":"2023-06-25T15:04:51+00:00","description":"Medical System Belgrade, specialized clinical research center in Serbia. New drugs and medication research. Phase 1-4 studies. IATA certified","breadcrumb":{"@id":"https:\/\/clinicaltrials.rs\/sr\/about-us\/#breadcrumb"},"inLanguage":"sr-RS","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clinicaltrials.rs\/sr\/about-us\/"]}]},{"@type":"ImageObject","inLanguage":"sr-RS","@id":"https:\/\/clinicaltrials.rs\/sr\/about-us\/#primaryimage","url":"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/12\/page-title.jpg","contentUrl":"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/12\/page-title.jpg","width":1920,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/clinicaltrials.rs\/sr\/about-us\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clinicaltrials.rs\/"},{"@type":"ListItem","position":2,"name":"About clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/clinicaltrials.rs\/#website","url":"https:\/\/clinicaltrials.rs\/","name":"MSB Centar za klini\u010dka ispitivanja","description":"Clinical Research Done Right","publisher":{"@id":"https:\/\/clinicaltrials.rs\/#organization"},"alternateName":"Centar za klini\u010dka ispitivanja","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clinicaltrials.rs\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sr-RS"},{"@type":"Organization","@id":"https:\/\/clinicaltrials.rs\/#organization","name":"MSB Centar za klini\u010dka ispitivanja","alternateName":"Clinical Research Center","url":"https:\/\/clinicaltrials.rs\/","logo":{"@type":"ImageObject","inLanguage":"sr-RS","@id":"https:\/\/clinicaltrials.rs\/#\/schema\/logo\/image\/","url":"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/10\/Web_Logo.png","contentUrl":"https:\/\/clinicaltrials.rs\/wp-content\/uploads\/2022\/10\/Web_Logo.png","width":400,"height":114,"caption":"MSB Clinical Research Center"},"image":{"@id":"https:\/\/clinicaltrials.rs\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/clinicaltrials.rs\/sr\/wp-json\/wp\/v2\/pages\/3470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinicaltrials.rs\/sr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/clinicaltrials.rs\/sr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/clinicaltrials.rs\/sr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinicaltrials.rs\/sr\/wp-json\/wp\/v2\/comments?post=3470"}],"version-history":[{"count":0,"href":"https:\/\/clinicaltrials.rs\/sr\/wp-json\/wp\/v2\/pages\/3470\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinicaltrials.rs\/sr\/wp-json\/wp\/v2\/media\/4067"}],"wp:attachment":[{"href":"https:\/\/clinicaltrials.rs\/sr\/wp-json\/wp\/v2\/media?parent=3470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}